Ultrasound-Guided Erector Spinae Plane Block Versus Thoracoscopically-Guided Intercostal Nerve Block in Video-Assisted Thoracoscopic Surgery
Prospective, Randomized Comparative Study of an Anesthesiological, Ultrasound-Guided "Erector Spinae Plane Block" (ESPB) Versus a Surgical, Thoracoscopically-Guided "Intercostal Nerve Block" (ICNB) in "Video-Assisted Thoracoscopic" (VATS) Procedures, Evaluating Postoperative Analgesic Consumption, Postoperative Pain Perception, and Duration of the Procedure
1 other identifier
interventional
72
1 country
1
Brief Summary
Effective postoperative pain management is essential after thoracic surgery. Insufficient pain control may impair breathing and coughing, increasing the risk of pulmonary complications such as collapsed lungs (atelectasis) or pneumonia. Although minimally invasive lung surgery (video-assisted thoracoscopic surgery, VATS) is less painful than open surgery, people can still have significant pain after the operation. The goal of this randomized comparative study is to compare two commonly used regional anesthesia techniques for pain control after VATS in adults. Researchers will compare an ultrasound-guided erector spinae plane block (ESPB), performed by anesthesiologists, to a thoracoscopically-guided intercostal nerve block (ICNB), performed by surgeons. Participants will:
- Undergo elective VATS lung resection surgery
- Receive either ESPB or ICNB, according to random assignment
- Have the received amount of analgesics recorded during the first 24 hours
- Have their pain levels assessed at predefined time points after surgery The main questions this study aims to answer are:
- Does ESPB result in similar analgesic consumption in the first 24 hours after surgery?
- Does ESPB provide similar postoperative pain relief compared to ICNB?
- Is the time needed to perform ESPB similar to ICNB?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 10, 2026
CompletedFirst Posted
Study publicly available on registry
April 17, 2026
CompletedStudy Start
First participant enrolled
May 4, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 3, 2027
May 1, 2026
April 1, 2026
12 months
April 10, 2026
April 27, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Assessment of the postoperative analgesic consumption within the first 24 hours after surgery
Postoperative analgesic consumption is recorded during the first 24 hours after surgery. Both total opioid consumption and use of non-opioid analgesics (e.g., metamizole, paracetamol) are documented.
First 24 hours after surgery
Secondary Outcomes (2)
Assessment of the postoperative pain perception using the Numeric Rating Scale (NRS) pain scale
First 24 hours after surgery
Duration of the chest wall block
Perioperatively
Other Outcomes (2)
Incidence of postoperative nausea and vomiting (PONV)
First 24 hours after surgery
Incidence of complications
First 24 hours after surgery
Study Arms (2)
Anesthesiological, Ultrasound-Guided "Erector Spine Plane Block" (ESPB)
ACTIVE COMPARATORSurgical, Thoracoscopically-Guided "Intercostal Nerve Block" (ICNB)
ACTIVE COMPARATORInterventions
The ultrasound-guided Erector Spinae Plane Block (ESPB) is performed by experienced anesthesiologists prior to induction of general anesthesia and before the start of surgery. Standard sterile precautions are applied. The fifth and sixth thoracic vertebrae are identified using anatomical landmarks and, if needed, ultrasound guidance. An ultrasound probe is positioned in a paramedian sagittal orientation approximately 2 cm lateral to the spinous process to visualize relevant anatomical structures. An in-plane needle technique is used, advancing the needle in a cranial-to-caudal direction under continuous ultrasound visualization. The needle tip is positioned in the subfascial plane beneath the erector spinae muscle at the level of the transverse process. Correct positioning is confirmed using hydrodissection. The local anesthetic is administered incrementally under continuous ultrasound guidance with repeated negative aspiration. A total of 25 mL of ropivacaine 0.375% is injected.
The thoracoscopically-guided Intercostal Nerve Block (ICNB) is performed by the surgeon intraoperatively immediately after insertion of the thoracoscope and before the start of surgery. Standard sterile precautions are applied. The block is performed percutaneously under continuous thoracoscopic visualization. The needle is advanced to the intercostal space, targeting the neurovascular bundle in the costal groove. Injections are performed at the level of the trocar insertion and in the two intercostal spaces cranial and caudal to it. The spread of the local anesthetic is visualized thoracoscopically to ensure correct placement and to avoid pleural perforation. A volume of 5 mL is administered per level, resulting in a total of 25 mL of ropivacaine 0.375%.
Eligibility Criteria
You may qualify if:
- Provision of written informed consent
- Adults (≥ 18 years of age)
- Elective video-assisted thoracoscopic surgery (VATS) for pulmonary resection (e.g., lobectomy, segmentectomy, wedge resection)
You may not qualify if:
- Lack of informed consent
- Language barrier
- Pregnancy or breastfeeding
- Known allergy to local anesthetics used in the study
- Infection at the injection site(s)
- History of complex chest wall surgery
- Revision surgery with a prior operation within the last 6 months
- Intraoperative conversion to open thoracotomy
- Chronic pain syndrome
- Fibromyalgia
- Chronic opioid use
- Chronic alcohol abuse
- Chronic substance abuse (e.g., THC, amphetamines, cocaine)
- History of psychiatric disorders (e.g., depression, schizophrenia)
- Impaired consciousness, cognition, or ability to communicate
- +2 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sana Klinikum Offenbach
Offenbach, Hesse, 63069, Germany
MeSH Terms
Interventions
Study Officials
- PRINCIPAL INVESTIGATOR
Haitham Mutlak, Prof. Dr.
Department of Anesthesiology, Intensive Care Medicine and Pain Therapy at Sana Klinikum Offenbach
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Head of Department of Anesthesiology
Study Record Dates
First Submitted
April 10, 2026
First Posted
April 17, 2026
Study Start
May 4, 2026
Primary Completion (Estimated)
April 30, 2027
Study Completion (Estimated)
May 3, 2027
Last Updated
May 1, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share